Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07275827 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 7 months later Apr 2026 → Dec 2026
See other at-risk trials from Tanta University

Record History

  1. Primary completion pushed from Apr 2026 to Dec 2026 Recruitment opened · Completion pushed from Oct 2026 to Feb 2027 · Site details revisedv3 Show 3 more changesShow less
    • Recruitment opened
    • Completion pushed from Oct 2026 to Feb 2027
    • Site details revised
  2. Start date: Dec 1, 2025 to Feb 1, 2026 Interventions: zinc sulfate (Drug) to Vonoprazan + amoxicillin + clarithromycin (Drug), proton pump inhibitor + amoxicillin (Drug), zinc sulfate (Drug) · Study description shortened, about 228 wordsv2 Show 2 more changesShow less
    • Interventions: zinc sulfate (Drug) to Vonoprazan + amoxicillin + clarithromycin (Drug), proton pump inhibitor + amoxicillin (Drug), zinc sulfate (Drug)
    • Study description shortened, about 228 words

    See this version in full on ClinicalTrials.gov ↗

  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
this Study Evaluating Safety and Effectiveness of (Proton Pump Inhibitor versus Vonoprazan) Based Triple Therapy with or without Zinc to Eradicate H. pylori Infection
Trial Details
NCT Number NCT07275827
Lead Sponsor Tanta University
Conditions HELICOBACTER PYLORI INFECTIONS
Enrollment 88 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov